de Verneuil Vanina 4
4 · Vir Biotechnology, Inc. · Filed Nov 4, 2025
Insider Transaction Report
Form 4
de Verneuil Vanina
EVP, General Counsel, Corp Sec
Transactions
- Sale
Common Stock
2025-11-03$5.86/sh−1,365$8,003→ 80,595 total
Footnotes (2)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F2]Includes 2,500 shares of common stock acquired by the Reporting Person on May 30, 2025 pursuant to an employee stock purchase program.